F S Brimblecombe, J Chamberlain. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anti-Bacterial Agents/therapeutic useChild Health ServicesCosts and Cost AnalysisCystic Fibrosis/diagnosisCystic Fibrosis/drug therapyCystic Fibrosis/geneticsCystic Fibrosis/mortalityCystic Fibrosis/therapyEnglandFemaleGenetic CounselingHumansInfantInfant, NewbornMass ScreeningMeconium/analysisPhysical Therapy ModalitiesPregnancySweat/analysisUnited States
Substances: See more » Anti-Bacterial Agents
Year: 1973 PMID: 4128736 DOI: 10.1016/s0140-6736(73)92815-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321